The evolution of the unstable cancer genome
- PMID: 24657538
- DOI: 10.1016/j.gde.2013.11.011
The evolution of the unstable cancer genome
Abstract
Cancer next-generation sequencing and genomics studies published over the last five years have provided unprecedented insights into the forces shaping cancer genome evolution. In particular, these studies have revealed a high level of heterogeneity not only between different tumours, but also within individual tumours; the 'cancer genome' may evolve along several independent trajectories within a single tumour. There is an increasing appreciation of the importance of intratumour genetic heterogeneity in determining disease progression and clinical outcome in cancer medicine, and thus an increasing awareness of the need to understand the processes that both generate genetic diversity and shape genome evolution in human tumours.
Copyright © 2013. Published by Elsevier Ltd.
Similar articles
-
Evolution of the cancer genome.Nat Rev Genet. 2012 Nov;13(11):795-806. doi: 10.1038/nrg3317. Epub 2012 Oct 9. Nat Rev Genet. 2012. PMID: 23044827 Free PMC article. Review.
-
Leveraging single-cell sequencing to unravel intratumour heterogeneity and tumour evolution in human cancers.J Pathol. 2022 Jul;257(4):466-478. doi: 10.1002/path.5914. Epub 2022 May 23. J Pathol. 2022. PMID: 35438189 Free PMC article. Review.
-
Cancer genome sequencing: understanding malignancy as a disease of the genome, its conformation, and its evolution.Cancer Lett. 2013 Nov 1;340(2):152-60. doi: 10.1016/j.canlet.2012.10.018. Epub 2012 Oct 27. Cancer Lett. 2013. PMID: 23111104 Free PMC article. Review.
-
Genetic and epigenetic heterogeneity in cancer: a genome-centric perspective.J Cell Physiol. 2009 Sep;220(3):538-47. doi: 10.1002/jcp.21799. J Cell Physiol. 2009. PMID: 19441078 Review.
-
Advances for studying clonal evolution in cancer.Cancer Lett. 2013 Nov 1;340(2):212-9. doi: 10.1016/j.canlet.2012.12.028. Epub 2013 Jan 23. Cancer Lett. 2013. PMID: 23353056 Free PMC article. Review.
Cited by
-
Turning the headlights on novel cancer biomarkers: Inspection of mechanics underlying intratumor heterogeneity.Mol Aspects Med. 2015 Nov;45:3-13. doi: 10.1016/j.mam.2015.05.001. Epub 2015 May 27. Mol Aspects Med. 2015. PMID: 26024970 Free PMC article. Review.
-
Molecular profiling and specific targeting of gemcitabine-resistant subclones in heterogeneous pancreatic cancer cell populations.Front Oncol. 2023 Aug 31;13:1230382. doi: 10.3389/fonc.2023.1230382. eCollection 2023. Front Oncol. 2023. PMID: 37719017 Free PMC article.
-
Single-cell genetic analysis of clonal dynamics in colorectal adenomas indicates CDX2 gain as a predictor of recurrence.Int J Cancer. 2019 Apr 1;144(7):1561-1573. doi: 10.1002/ijc.31869. Epub 2018 Dec 11. Int J Cancer. 2019. PMID: 30229897 Free PMC article.
-
KRAS oncogene in non-small cell lung cancer: clinical perspectives on the treatment of an old target.Mol Cancer. 2018 Feb 19;17(1):33. doi: 10.1186/s12943-018-0789-x. Mol Cancer. 2018. PMID: 29455666 Free PMC article. Review.
-
MAGERI: Computational pipeline for molecular-barcoded targeted resequencing.PLoS Comput Biol. 2017 May 5;13(5):e1005480. doi: 10.1371/journal.pcbi.1005480. eCollection 2017 May. PLoS Comput Biol. 2017. PMID: 28475621 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources